US Corporate Distress Financial Stress SEC Filings — February 19, 2026

20-02-2026

Green Thumb Industries Inc. filed a Form 8-K on February 20, 2026, disclosing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, accompanied by Regulation FD disclosure under Item 7.01 and financial statements/exhibits under Item 9.01. No specific transaction details, dollar values, or financial impacts are disclosed. This is a multi-item mandatory filing with no quantitative metrics provided.

20-02-2026

OFF THE HOOK YS INC. filed an 8-K on February 20, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, transaction size, or financial impacts disclosed in the provided information. No quantitative metrics, comparisons, or scheduled events are mentioned.

20-02-2026

Moleculin Biotech, Inc. filed an 8-K on February 20, 2026, disclosing entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, accompanied by financial statements and exhibits under Item 9.01. This multi-item filing signals potentially significant corporate actions such as financing or partnerships, common in biotech, but no quantitative details like transaction values, share counts, or financial impacts are disclosed. No positive or negative metrics are provided, resulting in purely informational disclosure.

20-02-2026

FIRST MID BANCSHARES, INC. filed an 8-K on 2026-02-20 reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific details on the agreement, transaction value, terms, or financial impact are provided.

20-02-2026

Wheeler Real Estate Investment Trust, Inc. filed a Form 8-K on 2026-02-20 disclosing entry into a material definitive agreement under Item 1.01 and changes involving departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers under Item 5.02. This is a multi-item mandatory filing with no financial metrics, transaction sizes, personnel names, or other quantitative details provided. No positive or negative performance metrics are mentioned.

20-02-2026

The company filed an 8-K on February 20, 2026 (AccNo: 0001193125-26-061053), reporting under Item 1.01 entry into a Material Definitive Agreement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on the agreement, events, transaction value, financial metrics, or impacts are disclosed in the provided filing summary. Critical transaction and financial data are missing, limiting assessment of implications.

20-02-2026

Exelon Corp filed an 8-K on 2026-02-20 reporting Item 1.01 Entry into a Material Definitive Agreement and Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, accompanied by exhibits under Item 9.01. No specific details, dollar values, financial impacts, positive or negative metrics, or strategic context are disclosed in the provided filing summary. This multi-item filing signals potentially material developments but lacks quantitative data for assessment.

20-02-2026

SRx Health Solutions, Inc. filed an 8-K on 2026-02-20 under Item 3.01 announcing a notice of delisting or failure to satisfy a continued listing rule or standard, with transfer of listing implications. Item 9.01 includes financial statements and exhibits. No financial metrics, transaction values, or specific reasons for delisting are disclosed.

• ·AccNo: 0001493152-26-007565
• ·File Size: 280 KB
• ·Sector: NOT_DISCLOSED

20-02-2026

Sigyn Therapeutics, Inc. filed a Form 8-K on February 20, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 3.02 unregistered sales of equity securities, with exhibits provided under Item 9.01. This multi-item filing signals a potentially strategic transaction but introduces equity dilution risk with no offsetting positive metrics disclosed. No quantitative details such as transaction values, share counts, or financial impacts are provided.

20-02-2026

Reliability Inc filed an 8-K on 2026-02-20 reporting under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits (AccNo: 0001493152-26-007579, file size 6 MB). This is a multi-item filing with no specific details provided on the agreement, events, parties, financial terms, or impacts. No quantitative metrics, comparisons, or forward-looking statements are disclosed.

20-02-2026

Hasbro, Inc. filed an 8-K on February 20, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, financial impacts, or performance metrics are provided.

20-02-2026

Southern California Edison Co filed an 8-K on 2026-02-20 reporting Item 1.01 entry into a material definitive agreement, Item 1.02 termination of a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and Item 9.01 financial statements and exhibits. No quantitative details such as transaction values, financial impacts, or specific terms are disclosed. This multi-item filing reflects both new commitments and terminations with unclear net effects.

20-02-2026

MSP Recovery, Inc. filed a Form 8-K on February 20, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits. No specific details, dollar values, personnel names, transaction terms, financial metrics, or impacts are disclosed in the provided filing summary.

20-02-2026

Cousins Properties Inc filed a Form 8-K on 2026-02-20 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, obligation size, strategic context, or financial impacts disclosed in the provided summary. No quantitative metrics, positive or negative changes, or period-over-period comparisons are mentioned.

20-02-2026

Cohen & Co Inc. filed an 8-K on 2026-02-20 disclosing under Item 1.01 entry into a material definitive agreement, while under Item 1.02 reporting termination of another material definitive agreement. Item 9.01 provides for financial statements and exhibits. The simultaneous entry and termination suggest strategic shifts, but no details on terms, impacts, or net effects are disclosed.

20-02-2026

OFS Capital Corp filed an 8-K on 2026-02-20 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 1.02 (Termination of a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing involving both new commitments and terminations, but no details on agreements, parties, terms, values, or impacts are disclosed. No quantitative metrics, period-over-period changes, or scheduled events are mentioned.

20-02-2026

Five9, Inc. filed an 8-K on 2026-02-20 reporting entry into a Material Definitive Agreement under Item 1.01, with Financial Statements and Exhibits under Item 9.01. This is a multi-item mandatory disclosure with no specific transaction details, parties, dollar values, or financial impacts provided. No positive or negative metrics are disclosed.

20-02-2026

TriSalus Life Sciences, Inc. filed an 8-K on February 20, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on the agreement, events, transaction value, financial impacts, or quantitative metrics are disclosed in the provided filing summary. This is a multi-item filing with no period-over-period comparisons, positive or negative metrics mentioned.

20-02-2026

Abpro Holdings, Inc. filed an 8-K on 2026-02-20 under Item 3.01 announcing a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No quantitative financial metrics, positive developments, or offsetting factors were disclosed. This event indicates a failure to meet listing requirements, with no details on reasons, timing, or impacts provided.

• ·Single-item 8-K filing (Item 3.01 only)
• ·Accession Number: 0001213900-26-018819
• ·File size: 243 KB
• ·Sector: NOT_DISCLOSED

20-02-2026

PulteGroup Inc/MI/ filed an 8-K on February 20, 2026, disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 references financial statements and exhibits. No specific details on the agreement, transaction value, financial impacts, or other metrics are provided.

20-02-2026

RXO, Inc. filed a Form 8-K on February 20, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and under Item 8.01 other events, with exhibits under Item 9.01. This is a multi-item mandatory disclosure for Items 1.01 and 2.03. No specific details on transaction value, parties, financial impact, or other metrics are disclosed.

20-02-2026

Gran Tierra Energy Inc. filed an 8-K on February 20, 2026 (AccNo: 0001104659-26-018158), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, parties, impacts, or metrics are disclosed.

• ·Filing size: 1 MB
• ·Sector: NOT_DISCLOSED

20-02-2026

Scilex Holding Co filed an 8-K on February 20, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 3.02 unregistered sales of equity securities. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, share counts, or financial impacts are disclosed.

20-02-2026

Faraday Future Intelligent Electric Inc. filed a Form 8-K on 2026-02-20 under Item 3.03 disclosing material modifications to rights of security holders and under Item 5.03 reporting amendments to articles of incorporation or bylaws or a change in fiscal year. Item 9.01 provides for financial statements and exhibits. No specific details, numerical values, positive or negative impacts, or further context on the changes are disclosed in the provided filing summary.

• ·AccNo: 0001213900-26-018808
• ·File Size: 295 KB

20-02-2026

Eastman Chemical Co filed a Form 8-K on 2026-02-20 under Item 1.01 disclosing entry into a material definitive agreement, Item 8.01 for other events, and Item 9.01 for financial statements and exhibits. This is a multi-item filing, but no specific details on the agreement, events, transaction size, financial impacts, or metrics are disclosed. The announcement signals potentially significant strategic developments, though lacking quantification or context for directional assessment.

20-02-2026

AMERICAN STATES WATER CO filed an 8-K on 2026-02-20 disclosing entry into a Material Definitive Agreement under Item 1.01, with Financial Statements and Exhibits attached under Item 9.01. No specific details on the agreement, transaction value, parties involved, financial impacts, or strategic rationale are disclosed in the provided filing summary. No quantitative metrics, period-over-period comparisons, positive or negative changes, or scheduled events are mentioned.

20-02-2026

Oramed Pharmaceuticals Inc. filed an 8-K on February 20, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details, transaction values, financial metrics, positive or negative impacts, or period-over-period comparisons are provided in the filing summary. This is a multi-item filing with no disclosed quantitative data or strategic context.

20-02-2026

Atossa Therapeutics, Inc. filed a Form 8-K on February 20, 2026, reporting under Item 1.01 the entry into a new material definitive agreement, potentially signaling strategic progress. However, under Item 1.02, it disclosed the termination of a prior material definitive agreement, which may introduce uncertainty or costs. Item 9.01 includes financial statements and exhibits, but no transaction values, parties, or financial impacts are disclosed.

20-02-2026

Carnival PLC filed an 8-K on 2026-02-20 reporting under Item 1.01 entry into a Material Definitive Agreement, with Item 9.01 disclosing Financial Statements and Exhibits. No quantitative metrics, transaction details, financial impacts, period-over-period comparisons, or other specifics such as dollar values, parties involved, or strategic context are disclosed.

20-02-2026

NovaBay Pharmaceuticals, Inc. filed an 8-K on February 20, 2026, disclosing under Item 3.03 material modifications to the rights of security holders and under Item 5.03 amendments to its articles of incorporation or bylaws or a change in fiscal year. Item 9.01 lists financial statements and exhibits. No specific details, financial impacts, or quantitative metrics regarding these changes are provided.

20-02-2026

Tyson Foods, Inc. filed a Form 8-K on 2026-02-20 reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No quantitative details such as transaction values, financial impacts, or period-over-period comparisons are disclosed. This is a multi-item filing with no positive or negative metrics provided.

20-02-2026

Rain Enhancement Technologies Holdco, Inc. filed an 8-K on February 20, 2026 (AccNo: 0001213900-26-018852), reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No financial metrics, transaction values, or additional details such as reasons for delisting, impacts, or sector context were disclosed. This event signals potential compliance or operational issues with no offsetting positive developments mentioned.

20-02-2026

Zurn Elkay Water Solutions Corp filed an 8-K on 2026-02-20 reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement). Item 9.01 discloses Financial Statements and Exhibits. No specific transaction details, dollar values, terms, positive or negative financial impacts, or other metrics are provided in the filing summary.

20-02-2026

Gabelli Multimedia Trust Inc. filed a Form 8-K on 2026-02-20 disclosing entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement, events, or exhibits provided. No quantitative financial metrics, positive or negative changes, or performance comparisons are disclosed.

20-02-2026

Jupiter Neurosciences, Inc. filed a Form 8-K on 2026-02-20 reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No quantitative metrics, dollar values, strategic details, or performance comparisons are disclosed.

20-02-2026

Ashford Hospitality Trust Inc filed an 8-K on 2026-02-20 under Item 1.01 disclosing entry into a Material Definitive Agreement. This is a single-item mandatory filing with no details provided on the agreement's parties, terms, value, or financial implications. No quantitative metrics, positive or negative performance indicators, or period-over-period comparisons were mentioned.

• ·AccNo: 0001232582-26-000021
• ·Event Date: 2026-02-20 (same as filing date)
• ·Sector: not specified

20-02-2026

Solstice Advanced Materials Inc. filed an 8-K on February 20, 2026, reporting Item 5.08 regarding Shareholder Nominations Pursuant to Exchange Act Rule 14a-11 and Item 8.01 Other Events. No quantitative financial metrics, transaction values, period-over-period comparisons, or specific details on the nominations or events were disclosed. This multi-item filing provides governance-related information without directional financial impact.

20-02-2026

RCI Hospitality Holdings, Inc. filed an 8-K on 2026-02-20 disclosing under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. Item 9.01 reports Financial Statements and Exhibits. No financial metrics, transaction values, or specific reasons for the delisting are disclosed.

• ·AccNo: 0001628280-26-010283
• ·File size: 193 KB
• ·Event date: February 20, 2026

20-02-2026

Pasithea Therapeutics Corp. filed a Form 8-K on 2026-02-20 (AccNo: 0001213900-26-018874) reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No financial metrics, transaction values, revenue implications, or other quantitative data are disclosed. This event signals potential non-compliance with exchange listing requirements.

20-02-2026

Hydrofarm Holdings Group, Inc. filed an 8-K on February 20, 2026, disclosing under Item 1.02 the termination of a material definitive agreement, which typically carries negative strategic implications. Item 8.01 reports other events, but no further details on positive offsets, financial impacts, or context are provided.

20-02-2026

Katapult Holdings, Inc. filed a Form 8-K on 2026-02-20 disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 reports financial statements and exhibits are included. No further details on the agreement, transaction value, parties, or financial impacts are disclosed.

• ·AccNo: 0000950103-26-002455
• ·File Size: 301 KB
• ·Sector: NOT_DISCLOSED

20-02-2026

CLOUDASTRUCTURE, INC. filed a Form 8-K on 2026-02-20 under Item 3.01 providing notice of delisting or failure to satisfy a continued listing rule or standard; transfer of listing. No quantitative financial metrics, transaction values, revenue impacts, or other details such as dollar amounts, percentages, or guidance changes were disclosed. This is a material regulatory event with no accompanying positive metrics reported.

• ·AccNo: 0001683168-26-001229
• ·File size: 197 KB
• ·Sector: NOT_DISCLOSED